SCHEMBL18968919

SCHEMBL18968919

CC1(C)c2cccc3c2-c2c1cccc2C3(c1ccccc1)c1cccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3ccc(-c4cccc5ccccc45)cc3)cc2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNB4 P30926 3/20 0.39
▸ CHRNA3 P32297 3/20 0.39
▸ CHRNA1 P02708 2/20 0.39
▸ CHRNG P07510 2/20 0.39
▸ CHRNB1 P11230 2/20 0.39
▸ CHRNB2 P17787 2/20 0.39
▸ SLC6A2 P23975 2/20 0.39
▸ SLC6A4 P31645 2/20 0.39
▸ CHRNA4 P43681 2/20 0.39
▸ SLC6A3 Q01959 2/20 0.39
▸ CHRND Q07001 2/20 0.39
▸ CA12 O43570 4/20 0.38
▸ CA1 P00915 4/20 0.38
▸ CA2 P00918 4/20 0.38
▸ CA9 Q16790 4/20 0.38
▸ CHRNA7 P36544 1/20 0.33
▸ SLC6A9 P48067 1/20 0.33
▸ PPARG P37231 8/20 0.33
▸ PPARA Q07869 8/20 0.33
▸ CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18968920 1.00 CHRNB4 (0.39) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL18968926 0.95 CHRNB4 (0.37) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL18968927 0.95 CHRNB4 (0.36) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL18968933 0.95 CHRNB4 (0.36) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL18968937 0.95 CHRNB4 (0.36) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL18968950 0.93 CA12 (0.36) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL18968941 0.93 CHRNB4 (0.35) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL18968938 0.92 CHRNB4 (0.36) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL18968989 0.90 CHRNA1 (0.35) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1
SCHEMBL18968963 0.89 SIGMAR1 (0.32) CHRNB4CHRNA3CHRNA1CHRNGCHRNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10361374-B2 Amine compound and organic light emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2019-07-23 — — US disclosed
US-20170170402-A1 AMINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-15 — — US disclosed
US-20170170402-A1 AMINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170170402-A1 AMINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME AOC2, MAOA, AOC3 CHRNB4 2472/4885CHRNA3 2217/4885CHRNA1 864/4885
US-10361374-B2 Amine compound and organic light emitting device including the same AOC2, MAOA, AOC3 CHRNB4 2472/4885CHRNA3 2217/4885CHRNA1 864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback